Staphylococcus epidermidis with intermediate resistance to vancomycin: Elusive phenotype or laboratory artifact?

Clinical Infectious Diseases

Volumn 33, Issue 1, 2001, Pages 135-137

  Dunne W M , Jr ^a   Qureshi, H ^a   Pervez, H ^a   Nafziger, D A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPEPTIDE; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; ARTIFACT; BACTERIAL PERITONITIS; CASE REPORT; FEMALE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; PHENOTYPE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; ARTIFACTS; CATHETERS, INDWELLING; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; LABORATORIES; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS; PHENOTYPE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 0034984814     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/320890     Document Type: Article

References (14)

1. Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides
2. Nosocomial bacteremia due to vancomycin-resistant Staphylococcus epidermidis in four patients with cancer, neutropenia, and previous treatment with vancomycin
3. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci
4. In-vitro characteristics of glycopeptide resistant strains of Staphylococcus epidermidis isolated from patients on CAPD
5. Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus
6. Emergence of vanocmycin resistance in coagulase-negative staphylococci
7. Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection
8. Bacteremia caused by staphylococci with inducible vancomycin heteroresistance
9. Reduced susceptibility of Staphylococccus aureus to vancomycin - Japan, 1996
10. Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997
11. Update: Staphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997
12. Vancomycin-resistant Staph: Epidemiology and therapeutic options
13. Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital
14. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital